ライフサイエンスコーパス: Gram-positive

1 nse is not well characterized, especially in Gram-positives.

2 an identify 24 etiologic agents of sepsis (8 Gram-positive, 11 Gram-negative, and 5 yeast species) an

3 rointestinal (20.4%), Gram negative (29.9%), Gram positive (16.8%), and culture negative (30.7%).

4 against clinically important gram-negative, gram-positive aerobic, and facultative bacteria includin

5 These new Gram-positive agents are reviewed here.

6 tified Dictyostelium chemotaxis towards live gram positive and gram negative bacteria and demonstrate

7 ith cis-diol groups on the cell wall of both gram positive and gram negative bacteria.

8 and RNA viruses including oncogenic viruses, gram positive and negative bacteria, fungi and parasites

9 amines were shown to exhibit potency against Gram-positive and -negative bacteria despite a contrary

10 LPPO II display excellent activities against Gram-positive and -negative bacteria, including pathogen

11 Notably, sTLR2 treatment markedly reduced Gram-positive and -negative bacteria-induced fibrosis in

12 posttrauma pneumonia susceptibility to both Gram-positive and -negative pathogens.

13 Pathogen-associated molecular patterns in gram-positive and gram-negative bacteria activate IL-1be

14 eported long-term biofilm resistance to both Gram-positive and Gram-negative bacteria and fungi: it r

15 ns are a diverse class of molecules found in Gram-positive and Gram-negative bacteria and most archae

16 monic nanoparticles can be delivered to both Gram-positive and Gram-negative bacteria boosting both p

17 munity, mediating AMP responses against both Gram-positive and Gram-negative bacteria in T. molitor.

18 IgE reactivity to antigens from Gram-positive and Gram-negative bacteria is common in pa

19 The outermost protective layer of both Gram-positive and Gram-negative bacteria is composed of

20 of antibacterial activity against a panel of Gram-positive and Gram-negative bacteria revealed struct

21 Images of gram-positive and gram-negative bacteria taken with this

22 lycan Recognition Proteins (PGRPs) kill both Gram-positive and Gram-negative bacteria through simulta

23 ureus and Escherichia coli as representative Gram-positive and Gram-negative bacteria under dark and

24 emonstrate that promysalin is active against Gram-positive and Gram-negative bacteria using a microdi

25 After two hours, Gram-positive and Gram-negative bacteria were reduced to

26 and NOD2 are intracellular sensors for both Gram-positive and Gram-negative bacteria, but their role

27 Using eight different species of Gram-positive and Gram-negative bacteria, we demonstrate

28 iviridae can infect commensal and pathogenic Gram-positive and Gram-negative bacteria.

29 ainst parasites, mycobacteria, and anaerobic Gram-positive and Gram-negative bacteria.

30 of community diversity and the ratio between Gram-positive and Gram-negative bacteria.

31 nstrated inhibitory activity against several gram-positive and gram-negative bacteria.

32 tion and antibacterial property against both Gram-positive and Gram-negative bacteria.

33 elicit potent antibacterial activity against Gram-positive and Gram-negative bacteria.

34 powerful antibacterial surfaces against both Gram-positive and Gram-negative bacteria.

35 ation of MurNAc residues that occurs in most Gram-positive and Gram-negative bacteria.

36 s a rapid bactericidal activity against both Gram-positive and Gram-negative bacteria.

37 olic extracts being highly effective against Gram-positive and Gram-negative bacteria; and (iii) the

38 f these building blocks into the backbone of Gram-positive and Gram-negative bacterial PG utilizing m

39 cation and susceptibility profiling for both Gram-positive and Gram-negative bacterial species requir

40 strain catalogue includes well-characterized gram-positive and gram-negative bacterial strains publis

41 (18)F-fluoromaltotriose was taken up in both gram-positive and gram-negative bacterial strains.

42 o investigate the in vitro susceptibility of Gram-positive and Gram-negative endophthalmitis bacteria

43 nd nonsmokers) demonstrated higher levels of gram-positive and gram-negative facultatives, and lower

44 displaying antibacterial activities against Gram-positive and Gram-negative pathogens (Staphylococcu

45 els of tetracycline- and multidrug-resistant Gram-positive and Gram-negative pathogens.

46 mical scaffolds that are active against both Gram-positive and Gram-negative pathogens.

47 l activity against multidrug resistant (MDR) Gram-positive and Gram-negative species.

48 altodextrin transporter that is expressed in gram-positive and gram-negative strains of bacteria.

49 Gram-positive and negative bacterial glycolipids were ex

50 s with three different bacteria species, one gram-positive and two gram-negative species, allowing th

51 acteria, while remaining insensitive to both Gram-positive and viral challenges.

52 trategy can also extend activity of specific Gram-positive antibiotics to Gram-negative bacteria.

53 by a toxin produced by Clostridium tetani-a Gram-positive bacillus found in high concentrations in s

54 structures for flagellar filaments from both Gram-positive Bacillus subtilis and Gram-negative Pseudo

55 Both extracts inhibited the growth of gram-positive (Bacillus cereus, Staphylococcus aureus, L

56 fferent stirring conditions on the growth of Gram-positive (Bacillus subtilis), Gram-negative (Escher

57 itory concentration (MIC) was much lower for Gram positive bacteria (Enterococcus spp. and Staphyloco

58 Gram positive bacteria are the major contributor of bact

59 ial activity against model Gram negative and Gram positive bacteria is reported for selected compound

60 They are more active against Gram positive bacteria than Gram negative bacteria; howe

61 covalently attached to the peptidoglycan of gram positive bacteria.

62 Its antibacterial activity is limited to gram positive bacteria.

63 bility in a wider range of Gram negative and Gram positive bacteria.

64 The highest ranked Gram-positive bacteria (high priority) were vancomycin-r

65 the formation of competence-induced pili in Gram-positive bacteria and corroborate the remarkable st

66 n a synthetic community of Gram-negative and Gram-positive bacteria and fungi.

67 uld be used for the quantitative analysis of Gram-positive bacteria and might be applied potentially

68 us of Zg16(-/-) animals had a higher load of Gram-positive bacteria and showed bacteria with higher m

69 Surface proteins in Gram-positive bacteria are incorporated into the cell wa

70 However, the mechanisms of MV formation in Gram-positive bacteria are unclear, as these cells posse

71 anscription in innate immunity, and identify Gram-positive bacteria as extracellular stimuli of Hippo

72 ver, treated cattle had reduced abundance of gram-positive bacteria at the genus level.

73 Gram-positive bacteria cause the majority of skin and so

74 al functions of specific compounds, and that Gram-positive bacteria considered to be obligate aerobes

75 The cell wall of Gram-positive bacteria contains abundant surface-exposed

76 The cell wall of most Gram-positive bacteria contains equal amounts of peptido

77 call NDA-1, contributes to the reduction of Gram-positive bacteria during early development and thus

78 ased on self-assembly of vancomycin (Van) on Gram-positive bacteria for imaging bacterial infection.

79 Given that Gram-positive bacteria genomes encode a variety of sorta

80 Regulators of PBP activity in Gram-positive bacteria have yet to be discovered but are

81 The presence of Gram-positive bacteria in foodstuffs is a chronic worldw

82 antibiotic with activity against a range of Gram-positive bacteria including drug-resistant pathogen

83 at cyclic-di-adenosine monophosphate in live Gram-positive bacteria is a vita-PAMP, engaging the inna

84 c IgG booster responses to Gram-negative and Gram-positive bacteria is contained solely within the B

85 Surface display of proteins by sortases in Gram-positive bacteria is crucial for bacterial fitness

86 or example, increasing drug resistance among gram-positive bacteria is responsible for approximately

87 The mechanism of persister formation in Gram-positive bacteria is unknown.

88 By contrast, Ntox28 domains from Gram-positive bacteria lack C-terminal Gly-Tyr-Gly-Ile m

89 in mechanism of action on gram-negative and gram-positive bacteria may be less pronounced than forme

90 sensitive and resistant Gram-negative and/or Gram-positive bacteria of new amphiphilic 3',4'-dialkyl

91 The DnaB primosomal protein from Gram-positive bacteria plays a key role in DNA replicati

92 Most low GC Gram-positive bacteria possess an essential walKR two-co

93 here enhances our understanding of how other Gram-positive bacteria produce essential components of t

94 Antimicrobial resistance in gram-positive bacteria remains a challenge in infectious

95 of complement by FH6-7/Fc on the surface of Gram-positive bacteria such as S. pyogenes will enable p

96 Streptococcus agalactiae are beta-hemolytic gram-positive bacteria that colonize the lower genital t

97 tibody-conjugated AuNPs can readily identify Gram-positive bacteria through antibody-antigen recognit

98 ns that mediate the attachment of pathogenic Gram-positive bacteria to host cells.

99 rticles (AuNP) modified with monoclonal anti-Gram-positive bacteria to produce an immune-sensor.

100 The more penetrable Zg16(-/-) mucus allowed Gram-positive bacteria to translocate to systemic tissue

101 Gram-positive bacteria use reactive thioester-containing

102 ZG16 bound to and aggregated Gram-positive bacteria via binding to the bacterial cell

103 delta, a small protein found in most Gram-positive bacteria was, for a long time, thought to

104 Gram-positive bacteria were responsible for a high propo

105 Gram-positive bacteria were sensitive to vancomycin (27/

106 Promysalin acts on Gram-positive bacteria with a mechanism of action involv

107 or of coproporphyrinogen oxidase (CgoX) from Gram-positive bacteria, an enzyme essential for heme bio

108 n shows broad antibacterial activity against Gram-positive bacteria, but is also hemolytic and cytoto

109 er regulator of carbon source utilization in gram-positive bacteria, but the CcpA regulon remains ill

110 In Gram-positive bacteria, CPS linkage is to either the cyt

111 However, in many Gram-positive bacteria, especially in fermicutes, RNAP i

112 In Gram-positive bacteria, extracellular protein appendages

113 ding Eukaryota, Homo sapiens, Viridiplantae, Gram-positive Bacteria, Gram-negative Bacteria and Virus

114 numerous antibiotic resistance plasmids from Gram-positive bacteria, Gram-negative phage and the mobi

115 shown to play a role in the pathogenesis of Gram-positive bacteria, including E. faecium We previous

116 t activity and antibacterial effects against Gram-positive bacteria, namely methicillin-susceptible S

117 Gram-positive bacteria, particularly coagulase-negative

118 basis for formation of the 100S complexes in Gram-positive bacteria, shedding light on the mechanism

119 al strains, including both Gram-negative and Gram-positive bacteria, showing great potential for appl

120 Pheromones of many gram-positive bacteria, such as Bacillus and Streptococc

121 s exhibited antibacterial activities against gram-positive bacteria, such as Bacillus subtilis and St

122 In other gram-positive bacteria, such as Enterococcus faecalis, d

123 environmental conditions, including, within Gram-positive bacteria, the stressosome complex that reg

124 glycopolymers found on the cell wall of many Gram-positive bacteria, whose diverse surface structures

125 edicine and nanotechnology.It is unclear how Gram-positive bacteria, with a thick cell wall, can rele

126 ss regulator Spx is ubiquitously found among Gram-positive bacteria.

127 oups by their hosts, either Gram-negative or Gram-positive bacteria.

128 xhibits potent antimicrobial effects against Gram-positive bacteria.

129 iscuous plasmids and their preference toward Gram-positive bacteria.

130 anding the biology of tectiviruses infecting Gram-positive bacteria.

131 hat displays nanomolar activity against many Gram-positive bacteria.

132 e opposite trend was observed in the case of Gram-positive bacteria.

133 vidin, recognizing almost none of the tested Gram-positive bacteria.

134 obal regulator of transcription in low G + C Gram-positive bacteria.

135 wn function that is well conserved in low-GC Gram-positive bacteria.

136 he CTC protein, a feature typical to various Gram-positive bacteria.

137 ive peptide/protein pairs we engineered from Gram-positive bacteria.

138 wn tropism of RNA bacteriophages may include gram-positive bacteria.

139 nificant antimicrobial effect, especially in gram-positive bacteria.

140 uses (bacteriophages) specifically infecting Gram-positive bacteria.

141 izes many types of PAMPs that originate from gram-positive bacteria.

142 peptides, and vulnerability to infection by Gram-positive bacteria.

143 epeat glycoproteins (SRRPs) are conserved in Gram-positive bacteria.

144 ich is linked to cell growth and division in Gram-positive bacteria.

145 , Staphylococci, and Streptococci, and other Gram-positive bacteria.

146 ates initiation of DNA replication in low-GC Gram-positive bacteria.

147 The most commonly identified organisms were gram-positive bacteria.

148 negative bacteria, but neither is present in Gram-positive bacteria.

149 gh which the stringent response functions in Gram-positive bacteria.

150 ossessed weak antibacterial activity against Gram-positive bacteria.

151 secretion systems in many Gram-negative and Gram-positive bacteria.

152 omplementing the method's proven utility for Gram-positive bacteria.

153 ring elongation in rod-shaped and ovococcoid Gram-positive bacteria.

154 tial target for evaluating antimicrobials in gram-positive bacteria.

155 whose hosts are Bacillus cereus and related Gram-positive bacteria.

156 dable in vitro activity against a variety of Gram-positive bacteria.

157 protein family, which is spread widely among gram-positive bacteria; and suggests approaches to targe

158 The Gram positive bacterial isolates were susceptible to cip

159 However, 65% of these Gram positive bacterial pathogens showed resistance to p

160 The proportion of Gram positive bacterial pathogens was (88%), and Staphyl

161 al design, through splitting a domain from a Gram-positive bacterial adhesin.

162 Recent structural studies on a class of Gram-positive bacterial adhesins have revealed an intram

163 Degradation of Gram-positive bacterial cell wall peptidoglycan in macro

164 polymers are omnipresent constituents of the Gram-positive bacterial cell wall where they fulfill a v

165 60-RNAi) enhanced drosomycin expression upon Gram-positive bacterial challenge but the basal drosomyc

166 rtant role in regulating innate immunity and gram-positive bacterial clearance by functioning, in par

167 Fatty acid kinase (Fak) is a ubiquitous Gram-positive bacterial enzyme consisting of an ATP-bind

168 ammatory response and host defense against a gram-positive bacterial infection.

169 ration of novel vaccine modalities to combat Gram-positive bacterial infections.

170 pposed to protective, role for IL-17A during Gram-positive bacterial infections.

171 Forty-four gram-positive bacterial isolates (57.9%), 17 gram-negati

172 stent with the idea that CcpA is critical to gram-positive bacterial pathogenesis.

173 Sepsis caused by Gram-positive bacterial pathogens is a major fatal disea

174 ococcus aureus and Streptococcus pneumoniae, Gram-positive bacterial pathogens of significant clinica

175 ogous pore-forming proteins secreted by many Gram-positive bacterial pathogens.

176 of peptidoglycan is integral to detection of gram-positive bacterial pathogens.

177 lated to the amounts of total microbial, and Gram-positive bacterial PLFAs, but not to the chemical c

178 t impacts on the amounts of total microbial, Gram-positive bacterial, and actinomycic PLFAs, but not

179 WMG1 shows dark toxicity to the Gram positive bacterium B. subtilis and good phototherma

180 ids as a positive determinant of size in the Gram-positive bacterium Bacillus subtilis and the single

181 Biofilms formed by the Gram-positive bacterium Bacillus subtilis depend on the

182 When starved, the Gram-positive bacterium Bacillus subtilis forms durable

183 troduce an isotopic labeling strategy in the gram-positive bacterium Bacillus subtilis to investigate

184 the solution structure of sigma1.1 from the Gram-positive bacterium Bacillus subtilis We found that

185 ment of oriC during spore development in the Gram-positive bacterium Bacillus subtilis.

186 Staphylococcus aureus, a Gram-positive bacterium colonizing nares, skin, and the

187 The Gram-positive bacterium Enterococcus faecalis is both a

188 lethanolamine halve during elongation of the Gram-positive bacterium Listeria innocua.

189 The Gram-positive bacterium Listeria monocytogenes transitio

190 or the stringent response nucleotides in the Gram-positive bacterium Staphylococcus aureus We demonst

191 terial immunotherapeutic protein against the Gram-positive bacterium Streptococcus pyogenes This prot

192 Listeria monocytogenes is an intracellular Gram-positive bacterium that induces expression of type

193 treptococcus agalactiae is a beta-hemolytic, Gram-positive bacterium that is a leading cause of neona

194 Bacillus anthracis is a sporulating Gram-positive bacterium that is the causative agent of a

195 te the properties of an ion channel from the Gram-positive bacterium Tsukamurella paurometabola with

196 Enterococcus faecalis, a Gram-positive bacterium, and Candida albicans, a fungus,

197 aphylococcus epidermidis (S. epidermidis), a Gram-positive bacterium, live inside the human nasal cav

198 ococcus suis, an important emerging zoonotic Gram-positive bacterium, while only RelA is functional u

199 ailed molecular characterisation of Tfp in a Gram-positive bacterium.

200 determinant of functional properties of the Gram-positive cell envelope.

201 stem bears striking resemblance to a related Gram-positive cell-wall remodeling strategy that also pr

202 iated with higher rates of positive FUBC for gram-positive cocci (GPC) but not GNB.

203 A total of 765 Bactec bottles demonstrating Gram-positive cocci in singles or clusters were tested d

204 comprising 10 Enterobacteriaceae isolates, 5 Gram-positive cocci, 5 Gram-negative nonfermenting speci

205 shes it from other staphylococci and related Gram-positive cocci.

206 The mission of the Gram-Positive Committee of the Antibacterial Resistance

207 TTOT (75.17 versus 43.06 h; P < 0.001), the Gram-positive contaminant TTOT (48.21 versus 11.75 h; P

208 ptide antibiotic with potent activity toward Gram-positive drug-resistant bacteria.

209 timal antibiotic choice for the treatment of Gram-positive endophthalmitis.

210 zers generally enhanced photoinactivation of Gram-positive facultative anaerobes (Ent. faecalis, Stap

211 o the virulence of Listeria monocytogenes, a Gram-positive facultative intracellular pathogen.

212 first physiological barrier breached by the Gram-positive facultative pathogen Listeria monocytogene

213 ication of novel periodontopathogens such as Gram-positive Filifactor alocis, but its virulence mecha

214 tics of the ADEP class inhibit the growth of Gram-positive firmicutes by activating ClpP and causing

215 tructurally conserved in other amidases from Gram-positive Firmicutes, are pivotal for enzymatic acti

216 and J showed antimicrobial activity against Gram positive foodborne pathogens (Listeria monocytogene

217 In recent years gram-positive (G(+)) bacteria, most commonly staphylococ

218 meningitidis, capsular serogroup C (MenC) or Gram-positive group B Streptococcus, capsular type III (

219 Planococcus is a Gram-positive halotolerant bacterial genus in the phylum

220 hes reveal occurrence of SPDIR events in the gram-positive human pathogen Streptococcus pneumoniae an

221 ptococcus (GAS, Streptococcus pyogenes) is a Gram-positive human pathogen that must adapt to unique h

222 Research on the Gram-positive human-restricted pathogen Streptococcus py

223 The TTOT for Gram-positive infection (GPI) was improved (64.04 versus

224 to discover non-antibiotic therapeutics for gram positive infections.

225 y lead to new therapeutic strategies against Gram-positive infections.

226 During infection with the Gram-positive intracellular pathogen Listeria monocytoge

227 Listeria monocytogenes is a Gram-positive intracellular pathogen that causes spontan

228 By contrast, the role of Hfq in Gram-positive is less established and varies among speci

229 None of the gram-positive isolates were vancomycin resistant.

230 we compared the immunomodulatory effects of Gram-positive (Lactobacillus rhamnosus strain GG [LGG])

231 nges in resistance patterns of the commensal Gram-positive microbiota.

232 Also, increased mass addition to Gram-positive mimetic membranes from AMP disruption corr

233 f the isoleucine biosynthesis pathway in the Gram-positive model bacterium Bacillus subtilis.

234 During phosphate-limited growth of the Gram-positive model organism Bacillus subtilis 168, WTA

235 coli dnaK mutants, rather than those in the Gram-positive model organism Bacillus subtilis.

236 xonuclease RNase J1 are not essential in the Gram-positive model organism,Bacillus subtilis, facilita

237 es in mortality risk were observed with both gram-positive (OR, 0.73; 95% CI, .55-.97) and gram-negat

238 inciting bacterial stimulus (gram-negative, gram-positive, or bacterial products).

239 st a variety of pathogenic Gram-negative and Gram-positive organisms is outlined.

240 postburn hospitalization, more susceptible, Gram-positive organisms predominate, whereas later more

241 gonorrheae and improved activity against the Gram-positive organisms Staphylococcus aureus and Entero

242 All Gram-positive organisms were susceptible to VAN, with th

243 natural product that is active only against Gram-positive organisms, into an antibiotic with activit

244 llenges for research of infections caused by gram-positive organisms.

245 oved antibacterial potency across a panel of Gram-positive organisms.

246 sponse pathway in enterococci and many other Gram-positive organisms.

247 ), Staphylococcus aureus (SA) (10.2%), other Gram-positive (other-GP) bacteria (7.4%) and Gram-negati

248 mall alarmone synthetase (SAS) RelQ from the Gram-positive pathogen Enterococcus faecalis is a sequen

249 The Gram-positive pathogen Staphylococcus aureus uses one pr

250 The cause might be allergic reactions to the gram-positive pathogen Staphylococcus aureus, a frequent

251 In the Gram-positive pathogen Staphylococcus aureus, the membra

252 up B Streptococcus (GBS) is an encapsulated, gram-positive pathogen that is an important cause of neo

253 Staphylococcus aureus is a Gram-positive pathogen that resists many facets of innat

254 phylococcus aureus, a metabolically flexible gram-positive pathogen, causes infections in a variety o

255 ctivity also increased significantly against gram positive pathogens.

256 selective bactericidal activity against key Gram-positive pathogens (including Staphylococcus aureus

257 ases in virulence for a variety of important Gram-positive pathogens and concludes with a discussion

258 somerase IV) display potent activity against Gram-positive pathogens and no target-mediated cross-res

259 Approved ARLG projects involving gram-positive pathogens include (1) a pharmacokinetics/p

260 By contrast, more than 92.0% of common Gram-positive pathogens remain susceptible to either pen

261 Investigating the susceptibility of various Gram-positive pathogens to histones, we found high-level

262 Recently, it was discovered that Gram-positive pathogens use a unique heme biosynthesis p

263 interacts with the cytoplasmic membranes of Gram-positive pathogens, causing membrane permeabilizati

264 For many gram-positive pathogens, conjugative plasmid transfer is

265 in (near-iron transporter [NEAT]), common in Gram-positive pathogens, elicits protection in a murine

266 Although effective against Gram-positive pathogens, novobiocin has limited activity

267 pton, which exhibits potent activity against Gram-positive pathogens.

268 moxazole; 68.3% of Gram-negative and 6.6% of Gram-positive pathogens.

269 hyrin III and leads to photosensitization of Gram-positive pathogens.

270 ry platform and class of materials to target Gram-positive pathogens.

271 own to enhance biofilm formation in multiple Gram-positive pathogens.

272 of CcpA targets in other medically relevant gram-positive pathogens.

273 ormation of biofilms by clinically important Gram-positive pathogens.

274 s exhibiting bactericidal activities against Gram-positive pathogens.

275 nes encoding fibronectin-binding proteins of Gram-positive pathogens.

276 cine candidate against enterococci and other gram-positive pathogens.

277 To uncover Gram-positive PBP regulatory factors, we used transposon

278 Here, we demonstrate a mechanism by which Gram-positive pili are able to dissipate mechanical ener

279 wever, little is known about the behavior of Gram-positive pili under force.

280 6, 27%), streptococci (32/126, 25.4%), and a Gram-positive rod (1/126, 0.8%).

281 zed by uncultivable asaccharolytic anaerobic Gram-positive rods and anaerobic Gram-negative rods, whi

282 nisms, uncultivable asaccharolytic anaerobic Gram-positive rods and other uncultivable Gram-negative

283 rity of these isolates are catalase-positive Gram-positive rods from multiple genera routinely classi

284 re non-spore forming, lactic acid producing, gram-positive rods.

285 Gram-positive S. aureus lacks an RMF homolog and the str

286 growth of model Gram-negative (E. coli) and Gram-positive (S. aureus) bacteria to a great extent.

287 n E. faecalis and other clinically-important Gram-positive species.

288 of the conjugate was determined against two gram positive (Staphyllococcus aureus and Enterococcus)

289 esponsible for hospital acquired infections: gram-positive Staphylococcus aureus and gram-negative Ps

290 By contrast, the Gram-positive Staphylococcus aureus cells appeared to be

291 In opportunistic Gram-positive Staphylococcus aureus, a small protein cal

292 inimum inhibitory concentrations against the Gram-positive Staphylococcus aureus.

293 d to successfully monitor the growth of both gram-positive (Staphylococcus aureus and Streptococcus p

294 synergistic antimicrobial activities against Gram-positive strains including methicillin-resistant St

295 owth much better than monobenzimidazoles for Gram-positive strains.

296 an important host defense mechanism against Gram-positive Streptococci.

297 In the gram-positive Streptococcus gordonii, the ability to for

298 ever, the signalling molecules recognized by Gram-positive stressosomes have yet to be identified, hi

299 not only the Gram-negative T6SS but also the Gram-positive type VII secretion system, a pathway recen

300 competent opportunistic human pathogen, is a Gram-positive workhorse for genomics.